Lantheus Holdings, Inc. (LNTH)
90.90
+4.75
(+5.51%)
USD |
NASDAQ |
May 07, 16:00
90.90
0.00 (0.00%)
After-Hours: 16:58
Lantheus Holdings SG&A Expense (TTM) : 453.81M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Anika Therapeutics, Inc. | 53.95M |
| BioCryst Pharmaceuticals, Inc. | 266.18M |
| Azenta, Inc. | 183.36M |
| Plus Therapeutics, Inc. | 12.13M |
| BioStem Technologies, Inc. | 132.72M |